Inha Kim

Inha Kim, MD, PhD, serves as the Head of Corporate Medical Affairs for Neuroscience and Rare Disease at Neuraxpharm since October 2024, focusing on launch excellence, life-cycle management, and strategic partnerships for business development. Previously, Inha held the position of Vice President and Head of Global Strategy and Communication in Medical Affairs at Lundbeck and served as Executive Director of Medical Affairs for Northern Europe at PTC Therapeutics, specializing in rare diseases and gene therapy. Inha's experience includes leadership roles at AstraZeneca, Olympus Surgical Technologies, Merz Pharmaceuticals, and sanofi-aventis, with a strong focus on medical affairs, clinical development, and market access. Inha's medical career began as a neurologist at Uniklinik Charite Berlin, emphasizing neuropsychological research and the treatment of various neurological disorders. Education includes an MD and PhD in Medicine from Freie Universität Berlin.